Signal2026-08-06
ClinicalTrials.gov

[EARLY_PHASE1] A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis

Part of

Dynamic Medicine And Treatment Timing